AML
Conference Coverage
Prevention of HMA failure a goal for high-risk MDS posttransplant
From the Journals
Beat AML: Precision medicine strategy feasible, superior to SOC for AML
"The study is changing significantly the way we look at treating patients with AML, showing that precision medicine ... can improve short- and...
Conference Coverage
Are HMAS appropriate for posttransplant maintenance in acute leukemias?
Not yet, hematologist/oncologist tells colleagues at ALF meeting.
Conference Coverage
Novel agents hold promise for frontline AML treatment
Conference Coverage
Standard treatment lacking in relapsed refractory AML
Feature
A uniquely patient-focused take on treating AML in older adults
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
Conference Coverage
AML maintenance: It’s now a thing
News
FDA approves first maintenance therapy for AML
Latest News
Don’t overlook treating older patients with acute promyelocytic leukemia, expert says
“Management options have changed dramatically with the advent of non–chemotherapy-based regimens.”
Conference Coverage
Combo drug improves survival in older patients with high-risk/secondary AML